A risk of malignancy index in preoperative diagnosis of ovarian cancer

Chinese Medical Journal

Volumn 116, Issue 3, 2003, Pages 396-399

  Ma, Shuiqing ^a   Shen, Keng ^a   Lang, Jinghe ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

CA125; Ovarian neoplasm; Risk of malignancy index

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; BENIGN TUMOR; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GYNECOLOGIC SURGERY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OVARY CANCER; PATHOLOGY; PATIENT SELECTION; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; ULTRASOUND;

CA-125 ANTIGEN; FEMALE; HUMANS; MENOPAUSE; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0037358831     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. The Surveillance Program, Division of Cancer Prevention and Control. Cancer Statistics Review 1973 - 1987. Washington DC: National Cancer Institute, 1988.
2. Gillis CR, Hole DJ, Still RM, et al. Medical audit, cancer registration, and survival in ovarian cancer. Lancet 1991;337: 611-612.
3. Tingulstad S, Hagen B, Skjeldestad FE, et al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynecol 1996;103:826-831.
4. Guidozzi F. Screening for ovarian cancer. Obstet Gynecol Surv 1996;51:696-701.
5. Zalel Y, Tepper R, Altaras M, et al. Transvaginal sonographic measurements of postmenopausal ovarian volume as a possible detection of ovarian neoplasia. Acta Obstet Gynecol Scand 1996; 75:668-671.
6. Schwartz PE, Taylor KJ. Is early detection of ovarian cancer possible? Ann Med 1995;27:519-528.
7. Tamakoshi K, Kikkawa F, Shibata K, et al. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Gynecol Oncol 1996;62:67-72.
8. Roman LD, Muderspach LI, Stein SM, et al. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Obstet Gynecol 1997;89:493-500.
9. Giuseppe M, Antonio la M, Antonino D, et al. Comparison of two malignancy risk indexes based on serum CA125, ultrasound score and menopausal status in the diagnosis of ovarian masses. Br J Obstet Gynecol 1999;106:524-527.
10. Solveig T, Bjorn H, Finn ES, et al. Evaluation of a risk of malignancy index based on CA125, ultrasound findings and menopausal status in the pre-operation diagnosis of pelvic masses. Br J Obstet Cynecol 1996;103:826-831.
11. Halia H, Stenman VH, Seppala M, et al. Ovarian cancer antigen CA125 level in pelvic inflamantory disease and pregnancy. Cancer 1986;57:1327-1329.